Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients
✍ Scribed by Cyrus Chargari; Youlia M. Kirova; Véronique Diéras; Pablo Castro Pena; Francois Campana; Paul H. Cottu; JeanYves Pierga; Alain Fourquet; Institut Curie Breast Cancer Study Group
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 82 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after whole‐brain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients
## Abstract ## BACKGROUND The majority of breast cancer patients with brain metastases receive whole‐brain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retr